Abstract

body fatness (3). Raised body mass index (BMI) is a major risk factor for non-communicable diseases such as: CVD (mainly heart disease and stroke), which were the lead- ing cause of death in 2012. In 2014, more than 1.9 billion adults, 18 years and older, were overweight. Of these over 600 million were obese. Overall, about 13% of the world's adult populations (11% of men and 15% of women) were obese. In 2014, 39% of adults aged 18 years and over (38% of men and 40% of women) were overweight. The world- wide prevalence of obesity more than doubled between 1980 and 2014. In this cross-sectional study, A total of 260 adult healthy men and women that being agreed by the chan- cellor and research deputy of Islamic Azad University of Hamadan. BMI (weight/height 2 in kg/m 2 ) was calculated for each participant. Obesity is defined as BMI 30 kg/m 2 . Blood samples were collected into the tube. CRP mea- surements were performed in the laboratory. The serum was transferred into plastic tube. Plasma CRP levels were measured by means of a colorimetric competitive enzyme- linked immunosorbent assay (ELISA). The results showed that prevalence of overweigh was 42.4% and the relation- ship between overweigh and CRP was P = 0.006. Waist cir- cumference in excess of 89 cm in men was 12.7% and in women waist circumference in excess of 89 cm was 21%. The overall prevalence of general obesity was 16.9% and was closely linked to CRP. Subjects with elevated CRP had higher BMI, WC (Waist circumference). For elevated CRP, subjects in the highest BMI quartile had compared with subjects in the lowest BMI quartile. The result shows the re- lationship of CRP with BMI throughout the BMI spectrum (P = 0.0002). CRP levels were strongly correlated with BMI (P = 0.0002). Levels of CRP also increased steadily across WC quartiles (P = 0.0001). Waist circumference quartiles were also strongly associated with odds of elevated CRP. Men in the highest WC (91 cm) and women in the highest WC (89 cm) had an odd of elevated CRP of 5.24 (95% CI, 3.15 - 14.0). Consequently, WHO has the unique authority and the clear mandate to lead the development and implemen- tation of the global strategy for the prevention and control of non-communicable diseases and thereby to create a bet- ter environment for world health in 2020 and beyond.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.